The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria

Journal of Biological Chemistry

Volumn 287, Issue 29, 2012, Pages 24734-24738

  Ramos, Theresa N ^a   Darley, Meghan M ^a   Weckbach, Sebastian ^b   Stahel, Philip F ^b   Tomlinson, Stephen ^c,d   Barnum, Scott R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONVERTASES; DEVELOPING WORLD; FATALITY RATES; MEMBRANE ATTACK COMPLEXES;

COAGULATION; DEVELOPING COUNTRIES; MAMMALS;

DISEASES;

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; FEMALE; INFECTION SENSITIVITY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C4; COMPLEMENT FACTOR B; MALARIA, CEREBRAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PLASMODIUM BERGHEI;

MURINAE; MUS;

EID: 84863794062     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C112.378364     Document Type: Article

References (44)

1. Guerra, C. A., Snow, R. W., and Hay, S. I. (2006) Mapping the global extent of malaria in 2005. Trends Parasitol. 22, 353-358
2. Haldar, K., Murphy, S. C., Milner, D. A., and Taylor, T. E. (2007) Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu. Rev. Pathol. 2, 217-249
3. Grau, G. E., and Craig, A. G. (2012) Cerebral malaria pathogenesis: revisiting parasite and host contributions. Future Microbiol. 7, 291-302
4. Silver, K. L., Higgins, S. J., McDonald, C. R., and Kain, K. C. (2010) Complement-driven innate immune response to malaria: fuelling severe malarial diseases. Cell Microbiol. 12, 1036-1045
5. Patel, S. N., Berghout, J., Lovegrove, F. E., Ayi, K., Conroy, A., Serghides, L., Min-oo, G., Gowda, D. C., Sarma, J. V., Rittirsch, D., Ward, P. A., Liles, W. C., Gros, P., and Kain, K. C. (2008) C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J. Exp. Med. 205, 1133-1143
6. Ramos, T. N., Darley, M. M., Hu, X., Billker, O., Rayner, J. C., Ahras, M., Wohler, J. E., and Barnum, S. R. (2011) Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. J. Immun. 186, 6657-6660
7. Wetsel, R. A., and Kolb, W. P. (1983) Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J. Exp. Med. 157, 2029-2048
8. Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., Gebhard, F., Younger, J. G., Drouin, S. M., Wetsel, R. A., and Ward, P. A. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687
9. Markiewski, M. M., Nilsson, B., Ekdahl, K. N., Mollnes, T. E., and Lambris, J. D. (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol. 28, 184-192
10. Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., and Huber-Lang, M. (2010) Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185, 5628-5636
11. Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., and Carroll, M. C. (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 92, 11490-11494
12. Matsumoto, M., Fukuda, W., Circolo, A., Goellner, J., Strauss-Schoenberger, J., Wang, X., Fujita, S., Hidvegi, T., Chaplin, D. D., and Colten, H. R. (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. U.S.A. 94, 8720-8725
13. Circolo, A., Garnier, G., Fukuda, W., Wang, X., Hidvegi, T., Szalai, A. J., Briles, D. E., Volanakis, J. E., Wetsel, R. A., and Colten, H. R. (1999) Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42, 135-149
14. Davoust, N., Nataf, S., Reiman, R., Holers, M. V., Campbell, I. L., and Barnum, S. R. (1999) Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J. Immunol. 163, 6551-6556
15. Sinden, R. E., Butcher, G. A., and Beetsma, A. L. (2002) Maintenance of the Plasmodium berghei life cycle. Methods Mol. Med. 72, 25-40
16. Leinhase, I., Rozanski, M., Harhausen, D., Thurman, J. M., Schmidt, O. I., Hossini, A. M., Taha, M. E., Rittirsch, D., Ward, P. A., Holers, V. M., Ertel, W., and Stahel, P. F. (2007) Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J. Neuroinflammation 4, 13
17. Wohler, J. E., Smith, S. S., Zinn, K. R., Bullard, D. C., and Barnum, S. R. (2009) γδ T cells in EAE: early trafficking events and cytokine requirements. Eur. J. Immunol. 39, 1516-1526
18. Atkinson, C., Song, H., Lu, B., Qiao, F., Burns, T. A., Holers, V. M., Tsokos, G. C., and Tomlinson, S. (2005) Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115, 2444-2453
19. Lou, J., Lucas, R., and Grau, G. E. (2001) Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14, 810-820
20. Ohno, T., and Nishimura, M. (2004) Detection of a new cerebral malaria susceptibility locus, using CBA mice. Immunogenetics 56, 675-678
21. Delahaye, N. F., Coltel, N., Puthier, D., Flori, L., Houlgatte, R., Iraqi, F. A., Nguyen, C., Grau, G. E., and Rihet, P. (2006) Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J. Infect. Dis. 193, 312-321
22. Qiao, F., Atkinson, C., Song, H., Pannu, R., Singh, I., and Tomlinson, S. (2006) Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am. J. Pathol. 169, 1039-1047
23. Read, R. W., Szalai, A. J., Vogt, S. D., McGwin, G., and Barnum, S. R. (2006) Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp. Eye Res. 82, 389-394
24. Barnum, S. R., and Szalai, A. J. (2006) Complement and demyelinating disease: no MAC needed? Brain Res. Rev. 52, 58-68
25. Stahel, P. F., and Barnum, S. R. (2006) The role of the complement system in CNS inflammatory diseases. Expert Rev. Clin. Immunol. 2, 445-456
26. Dasari, P., Heber, S. D., Beisele, M., Torzewski, M., Reifenberg, K., Orning, C., Fries, A., Zapf, A. L., Baumeister, S., Lingelbach, K., Udomsangpetch, R., Bhakdi, S. C., Reiss, K., and Bhakdi, S. (2012) Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation. Blood 119, 4301-4310
27. Glew, R. H., Atkinson, J. P., Frank, M. M., Collins, W. E., and Neva, F. A. (1975) Serum complement and immunity in experimental simian malaria. I. Cyclical alterations in C4 related to schizont rupture. J. Infect Dis. 131, 17-25
28. Atkinson, J. P., Glew, R. H., Neva, F. A., and Frank, M. M. (1975) Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity. J. Infect Dis. 131, 26-33
29. Ward, P. A., Sterzel, R. B., Lucia, H. L., Campbell, G. H., and Jack, R. M. (1981) Complement does not facilitate plasmodial infections. J. Immunol. 126, 1826-1828
30. Gabriel, J., and Berzins, K. (1983) Specific lysis of Plasmodium yoelii-infected mouse erythrocytes with antibody and complement. Clin. Exp. Immunol. 52, 129-134
31. Healer, J., McGuinness, D., Hopcroft, P., Haley, S., Carter, R., and Riley, E. (1997) Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect. Immun. 65, 3017-3023
32. Pang, X. L., and Horii, T. (1998) Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). Vaccine 16, 1299-1305
33. Ghosh, K., and Shetty, S. (2008) Blood coagulation in falciparum malaria: a review. Parasitol. Res. 102, 571-576
34. Moxon, C. A., Heyderman, R. S., and Wassmer, S. C. (2009) Dysregulation of coagulation in cerebral malaria. Mol. Biochem. Parasitol. 166, 99-108
35. Reinartz, J., Hänsch, G. M., and Kramer, M. D. (1995) Complement component C7 is a plasminogen-binding protein. J. Immunol. 154, 844-850
36. Christiansen, V. J., Sims, P. J., and Hamilton, K. K. (1997) Complement C5b-9 increases plasminogen binding and activation on human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 164-171
37. Skattum, L., van Deuren, M., van der Poll, T., and Truedsson, L. (2011) Complement deficiency states and associated infections. Mol. Immunol. 48, 1643-1655
38. Zhu, Z., Atkinson, T. P., Hovanky, K. T., Boppana, S. B., Dai, Y. L., Densen, P., Go, R. C., Jablecki, J. S., and Volanakis, J. E. (2000) High prevalence of complement component C6 deficiency among African Americans in the southeastern USA. Clin. Exp. Immunol. 119, 305-310
39. Hobart, M. J., Fernie, B. A., Fijen, K. A., and Orren, A. (1998) The molecular basis of C6 deficiency in the western Cape, South Africa. Hum. Genet. 103, 506-512
40. Würzner, R. (2003) Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit? Clin. Exp. Immunol. 133, 156-159
41. Malowany, J. I., and Butany, J. (2012) Pathology of sickle cell disease. Semin. Diagn. Pathol. 29, 49-55
42. Waisberg, M., Tarasenko, T., Vickers, B. K., Scott, B. L., Willcocks, L. C., Molina-Cruz, A., Pierce, M. A., Huang, C. Y., Torres-Velez, F. J., Smith, K. G., Barillas-Mury, C., Miller, L. H., Pierce, S. K., and Bolland, S. (2011) Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc. Natl. Acad. Sci. U.S.A. 108, 1122-1127
43. Ramos, T. N., Wohler, J. E., and Barnum, S. R. (2009) Deletion of both the C3a and the C5a receptors fails to protect against experimental autoimmune encephalomyelitis. Neurosci. Lett. 467, 234-236
44. World Health Organization (2011) World Malaria Report 2011, World Health Organization, Geneva, Switzerland